Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large-scale phosphoproteomics reveals activation of the MAPK/GADD45β/P38 axis and cell cycle inhibition in response to BMP9 and BMP10 stimulation in endothelial cells. | Cell Commun Signal | 2024 | 38439036 | PubTator, text mining | PubMed |
| Genome sequencing identify chromosome 9 inversions disrupting ENG in 2 unrelated HHT families. | Eur J Med Genet | 2024 | 38355093 | PubTator, text mining | PubMed |
| Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells. | Cells | 2024 | 38334677 | PubTator, text mining | PubMed |
| A Generalized Higher-order Correlation Analysis Framework for Multi-Omics Network Inference. | bioRxiv | 2024 | 38328226 | PubTator, text mining | PubMed |
| Blood flow regulates acvrl1 transcription via ligand-dependent Alk1 activity. | bioRxiv | 2024 | 38328175 | PubTator, text mining | PubMed |
| Inflammatory myofibroblastic tumor of the heart in an older woman with paroxysmal atrial fibrillation: a case report and review of the literature. | J Cardiothorac Surg | 2024 | 38310322 | PubTator, text mining | PubMed |
| Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors. | Angiogenesis | 2024 | 38294582 | PubTator, text mining | PubMed |
| Evaluation of Immunohistochemical Expression of ALK-1 in Gliomas, WHO Grade 4 and Its Correlation with IDH1-R132H Mutation Status. | Asian Pac J Cancer Prev | 2024 | 38285799 | PubTator, text mining | PubMed |
| Recurrent Epistaxis and Purple Vascular Stains in an Elderly Patient. | Indian Dermatol Online J | 2024 | 38283013 | PubTator, text mining | PubMed |
| Assessment of the effectiveness of the peptide inhibitor homologous to the transforming growth factor β cytokine blocking the TGFβRI/TGFβRII receptor complex-pilot study. | Clin Transl Allergy | 2024 | 38282199 | PubTator, text mining | PubMed |
| A Rare Association: Hereditary Hemorrhagic Telangiectasia with Liver Cirrhosis Causing Portal Hypertension. | Case Rep Gastrointest Med | 2024 | 38273971 | PubTator, text mining | PubMed |
| The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease. | Cell Res | 2024 | 38267638 | PubTator, text mining | PubMed |
| Lrg1 silencing attenuates ischemia-reperfusion renal injury by regulating autophagy and apoptosis through the TGFβ1- Smad1/5 signaling pathway. | Arch Biochem Biophys | 2024 | 38246328 | PubTator, text mining | PubMed |
| Dermatofibrosarcoma protuberans of the breast in pregnancy. | J Surg Case Rep | 2024 | 38239379 | PubTator, text mining | PubMed |
| Stereotactic radiosurgery for brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. | Acta Neurochir (Wien) | 2024 | 38231447 | PubTator, text mining | PubMed |
| Immunohistochemical expression of anaplastic lymphoma kinase in neuroblastoma and its relations with some clinical and histopathological features. | J Pathol Transl Med | 2024 | 38229432 | PubTator, text mining | PubMed |
| Functional characterization of variants found in Japanese patients with hereditary hemorrhagic telangiectasia. | Clin Genet | 2024 | 38225712 | PubTator, text mining | PubMed |
| Application of LRG mechanism in normal pressure hydrocephalus. | Heliyon | 2024 | 38223707 | PubTator, text mining | PubMed |
| Treatment of Hereditary Haemorrhagic Telangiectasia with Bevacizumab - What More Needs to be Known? | Eur J Case Rep Intern Med | 2024 | 38223286 | PubTator, text mining | PubMed |
| Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). | Respir Res | 2024 | 38218783 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=10